Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE)

Lupus

Volumn 6, Issue 1, 1997, Pages 57-62

  Granados, J ^a   Vargas Alarcon G ^a   Drenkard, C ^a   Andrade, F ^a   Melin Aldana H ^a   Alcocer Varela, J ^a   Alarcon Segovia D ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Anticardiolipin antibodies; Antiphospholipid antibodies; Antiphospholipid syndrome; Autoimmunity; Major histocompatibility complex; Systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; HLA DQ ANTIGEN; HLA DR3 ANTIGEN; HLA DR7 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ALLELE; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MEXICO; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031036799     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339700600108     Document Type: Article

References (41)

1. Alarcón-Segovia D et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989; 68: 353-365.
2. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990; 112: 682-698.
3. Conley CL, Hartman C. A haemorragic disorder caused by circulating anticoagulants in patients with disseminated lupus erythematosus. J Clin Invest 1953; 31: 621-623.
4. Exner T, Richard KA, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Hematol 1978; 40: 143-151.
5. Harris EN et al. Anticardiolipin antibodies: detection by radio- immunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; ii: 1211-1214.
6. Loizou S et al. Measurement of anticardiolipin antibodies by an enzime-linked immunosorbent assay (ELISA): Standardization and quantitation of results. Clin Exp Immunol 1985; 62: 738-745.
7. Alarcón-Segovia D, Sánchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16: 482-489.
8. Alarcón-Segovia D. Pathogenethic potential of antiphospholipid antibodies. J Rheumatol 1988; 15: 890-893.
9. Reinertsen JL et al. B-lymphocyte alloantigens associated with systemic lupus erythematosus. N Eng J Med 1978; 299: 515-518.
10. Gibofsky A et al. Disease associations of the Ia-like human alloantigens associated with systemic lupus erythematosus. J Exp Med 1978; 148: 1728-1732.
11. Bell DA, Maddison PJ. Serologic subsets in systemic lupus erythematosus. An examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum 1980; 23: 1268-1273.
12. Ahearn JM et al. Interrelationships of HLA-DR, MB and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1031-1040.
13. Gammon WR et al. Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II associated. J Invest Dermatol 1982; 91: 228-232.
14. Savi M et al. HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients. Arthritis Rheum 1988; 31: 1568-1570.
15. McHugh NJ, Maddison PJ. HLA-DR antigens and anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1623-1624.
16. Arnett FC, Olsen ML, Anderson KL, Reveille JD. Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant. J Clin Invest 1991; 87: 1490-1495.
17. Granados J et al. The role of HLA-DR alleles and complotypes through the ethnic barrier in Mexican SLE patients. Lupus 1996; 5: 184-189.
18. Vargas-Alarcón G et al. Association of HLA-DR5 (possibly DRB1*1201) with the primary antiphospholipid syndrome in Mexican patients. Arthritis Rheum 1995; 38: 1340-1341.
19. Alarcón-Segovia D et al. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Seminars in Arthritis Rheum 1992; 21: 275-286.
20. Weckmann AL et al. Frequency of HLA-A and HLA-B alleles in a Mexico City Mestizo group. Am J Hum Biology 1996; (in press).
21. De Leo Cet al. Population analysis of class I and class II MHC loci obtained from family studies in Mexicans. (Submitted for publication).
22. Granados J et al. Frequency of complotypes in Mexicans. Immunología 1996; (in press).
23. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies: Isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46: 1-6.
24. Delezé M, Oria CV, Alarcón-Segovia D. Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans' syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol 1988; 15: 611-615.
25. Boyum A. Isolation of leukocytes from human blood: further observations. Scand J Clin Lab Invest 1968; 97 (Suppl): 31.
26. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964; 204: 998.
27. Bodmer JG, Pickbourne P, Richards S. Ia serology. In: Bodmer WF, Barchelor JR, Bodmer JG, Festenstein H, Morris PJ (Eds) Histocompatibility Testing 1977. Munksgaard: Copenhagen, 1977.
28. Alper CA, Boenisch T, Watson L. Genetic polymorphism in human glycine-rich beta-glycoprotein. J Exp Med 1972; 135: 68-80.
29. Awdeh ZL, Alper CA. Inherited structural polymorphism of the forth component of human complement. Proc Natl Acad Sci USA 1980; 77: 3576-3580.
30. Alper CA. Inherited structural polymorphism in human C2: evidence for linkage between C2 and Bf. J Exp Med 1976; 144: 1111-1115.
31. Alarcón-Segovia D et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989; 68: 353-365.
32. Hartung K et al. MHC gene products and anticardiolipin antibodies in systemic lupus erythematosus results of a multicenter study. SLE study group. Autoimmunity 1992; 13: 95-99.
33. Cabiedes J, Cabral AP, Alarcón-Segovia D. Clinical manifestations of the antiphospholipid syndrome in systemic lupus erythematosus patients associated more strongly with anti-beta 2 glycoprotein-1 than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899-1906.
34. Goldstein R, Smith CD, Sengar DPS. MHC class II studies of primary antiphospholipid antibody (APLA) syndrome and of serum antiphospholipid antibodies in systemic lupus erythematosus (SLE). Arth Rheum 1990; 33: S125 (abstract).
35. Vargas-Alarcón G et al. Association of HLA-DR5 (possibly DRB1*1201) with the primary antiphospholipid syndrome in Mexican patients. Arthritis and Rheumatism 1995; 38: 1340-1343.
36. Camps MT et al. Immunogenetics characteristics of lupus patients with secondary antiphospholipid syndrome. Lupus 1995; 4: 22S (abstract).
37. Wilson WA, Perez MC, Michalski JP, Armatis PE. Cardiolipin antibodies and null alleles of C4 in Black Americans with systemic lupus erythematosus. J Rheumatology 1988; 15: 1768-1772.
38. Petri M, Watson R, Winkelstein JA, McLean RH. Clinical expression of systemic lupus erythematosus in patients with C4A deficiency. Medicine 1993; 72: 236-244.
39. Lisker R et al. Gene frequencies and admixture estimates in a Mexican city population. Am J Physical Anthropol 1986; 71: 203-207.
40. Lisker R, Pérez-Briceño R, Granados J, Babinksy V. Gene frequencies and admixture estimates in the State of Puebla, Mexico. Am J Physical Anthropol 1988; 76: 331-335.
41. Lisker R et al. Gene frequencies and admixture estimates in four Mexican Urban Centers. Hum Biology 1990; 62: 791-801.